Becker's Healthcare April 5, 2024
The American Society of Health-System Pharmacists partly welcomed HHS’ 18-page policy recommendations for drug shortage strategies, but the organization said it “proposes concerning penalties.”
On April 2, HHS recommended Congress create programs that assess and rank drug manufacturers based on their reliability. Hospitals would then be rewarded or penalized depending on their purchasing habits from diverse, reliable suppliers.
Based on a company’s scorecard, CMS could hand incentives or penalties to drugmakers, hospitals and middlemen. HHS said the current pharmaceutical industry prioritizes low costs, but some experts argue cheap generics deter pharmaceutical companies from protecting generic manufacturing lines, such as having resiliency...
Today's Sponsors
Today's Sponsor